Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · USD
$35.0
-0.09 (-0.3%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first ROIV analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 25.2B | |
|---|---|---|
| Revenue (ttm) | 8.3M | |
| Net income (ttm) | -299.8M | |
| EPS (ttm) | -$0.54 | |
| Shares out | 719.3M | |
| Volume | 4,043,202 | |
| Beta | 1.11 | |
| Price target | $38.4 | +9.5% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 8.3M
- Net income (ttm)
- -299.8M
- EPS (ttm)
- -$0.54
- Market cap
- 25.2B
Fair-value bridge
- Current price
- $35.0
Analyst consensus
Recommendation
Strong Buy
Price target
$38.4
+9.5%
In the news
Latest news · ROIV
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 25.2B
- P/S
- 3048.6x
- P/B
- 5.6x
Profitability
- Operating margin
- -15495.2%
- ROE
- -7.6%
- ROA
- -14.4%
- ROIC
- -154.1%
Balance sheet
- Debt / equity
- 0.02
- Current ratio
- 18.37
- Quick ratio
- 18.00
Trading
- Beta
- 1.11
- Volume
- 4,043,202
- Dividend yield
- 0.0%